Immutep Limited Stock Current Valuation
PRRUF Stock | USD 0.24 0.00 0.00% |
Valuation analysis of Immutep Limited helps investors to measure Immutep's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Immutep's price fluctuation is abnormally volatile at this time. Calculation of the real value of Immutep Limited is based on 3 months time horizon. Increasing Immutep's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Immutep Limited is useful when determining the fair value of the Immutep pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Immutep. Since Immutep is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Immutep Pink Sheet. However, Immutep's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.24 | Real 0.2 | Hype 0.24 |
The real value of Immutep Pink Sheet, also known as its intrinsic value, is the underlying worth of Immutep Limited Company, which is reflected in its stock price. It is based on Immutep's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Immutep's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Immutep's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Immutep Limited helps investors to forecast how Immutep pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Immutep more accurately as focusing exclusively on Immutep's fundamentals will not take into account other important factors: Immutep Limited Company Current Valuation Analysis
Immutep's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Immutep Current Valuation | 142.99 M |
Most of Immutep's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immutep Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Immutep Limited has a Current Valuation of 142.99 M. This is 99.0% lower than that of the Healthcare sector and 96.92% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.14% higher than that of the company.
Immutep Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immutep's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics of similar companies.Immutep is currently under evaluation in current valuation category among related companies.
Immutep Fundamentals
Return On Equity | -0.38 | |||
Return On Asset | -0.23 | |||
Operating Margin | (7.18) % | |||
Current Valuation | 142.99 M | |||
Shares Outstanding | 879.09 M | |||
Shares Owned By Insiders | 4.61 % | |||
Shares Owned By Institutions | 24.04 % | |||
Price To Earning | (2.50) X | |||
Price To Book | 2.81 X | |||
Price To Sales | 33.12 X | |||
Revenue | 247.66 K | |||
Gross Profit | (26.63 M) | |||
EBITDA | (43.69 M) | |||
Net Income | (32.21 M) | |||
Cash And Equivalents | 80 M | |||
Cash Per Share | 0.09 X | |||
Total Debt | 2.11 M | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 14.16 X | |||
Book Value Per Share | 0.11 X | |||
Cash Flow From Operations | (30.23 M) | |||
Earnings Per Share | (0.02) X | |||
Number Of Employees | 17 | |||
Beta | 1.95 | |||
Market Capitalization | 171.77 M | |||
Total Asset | 148.52 M | |||
Retained Earnings | (222 M) | |||
Working Capital | 21 M | |||
Current Asset | 22 M | |||
Current Liabilities | 1000 K | |||
Z Score | 47.2 | |||
Net Asset | 148.52 M |
About Immutep Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immutep Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immutep in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immutep's short interest history, or implied volatility extrapolated from Immutep options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immutep Limited using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Immutep Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |